| Filed | Form | Description | |
|---|---|---|---|
| 4/15/25 | DEFA14A | DEFA14A | → |
| 4/15/25 | DEF 14A | DEF 14A | → |
| 4/4/25 | PRE 14A | PRE 14A | → |
| 4/25/24 | DEFA14A | DEFA14A | → |
| 4/25/24 | DEF 14A | DEF 14A | → |
| 1/12/24 | DEFA14A | DEFA14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 2/19/26 | 4 | 4 | → |
| 2/19/26 | 4 | 4 | → |
| 2/19/26 | 4 | 4 | → |
| 2/19/26 | 4 | 4 | → |
| 1/22/26 | 4 | 4 | → |
| 1/22/26 | 4 | 4 | → |
| ↓ | |||
Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina.